Evidence map›Paper›PMID 40366936›Full record

ArticleRevista brasileira de epidemiologia = Brazilian journal of epidemiology2025

Therapeutic modalities in the first cancer treatment: percentage variation before and during the pandemic, in Ceará, a state in the Northeast region of Brazil.

Stefane Vieira Nobre, Miren Maite Uribe Arregi, Thereza Maria Magalhães Moreira, Antonio Germane Alves Pinto, Marcelo Gurgel Carlos da Silva

Abstract read
In one paragraph

Article in Revista brasileira de epidemiologia = Brazilian journal of epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Stefane Vieira NobreUniversidade Estadual do Ceará - Fortaleza (CE), Brazil.ORCID http://orcid.org/0000-0003-4354-2494
Miren Maite Uribe ArregiCentro Regional Integrado de Oncologia - Fortaleza (CE), Brazil.ORCID http://orcid.org/0000-0002-3839-8056
Thereza Maria Magalhães MoreiraUniversidade Estadual do Ceará - Fortaleza (CE), Brazil.ORCID http://orcid.org/0000-0003-1424-0649
Antonio Germane Alves PintoUniversidade Regional do Cariri - Fortaleza (CE), Brazil.ORCID http://orcid.org/0000-0002-4897-1178
Marcelo Gurgel Carlos da SilvaUniversidade Estadual do Ceará - Fortaleza (CE), Brazil.ORCID http://orcid.org/0000-0003-4030-1206

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the percentage variation of the different therapeutic modalities used in new cases of cancer, before and during the pandemic, in Ceará.

methodsDescriptive study with information from records of the Hospital Information System and Authorization of Highly Complex Procedures, and Cancer Information Systems in the state of Ceará, Brazil.

resultsThere was a reduction of 2,575 (-30.85%) new cases in 2020 and 2,368 (-28.37%) in 2021. Regarding the therapeutic modalities, it was possible to observe that there were decreases in the numbers of all institutions in the first cancer treatment, except for isolated radiotherapy and for combined surgery+iodine therapy+radiotherapy. Surgery was the modality most often performed in a timely manner (<30 days) and chemotherapy in an untimely manner (>60 days). The impact on the initiation of timely treatment (<30 days after diagnosis) was greater in 2021 than in 2020. In general, late treatments (>60 days) were lower than in 2019. The period of 31-60 days was shown to be above 2019 almost the entire year, in 2020 and 2021.

conclusionThe number of new cancer cases in Ceará may occur during the pandemic. This situation impacted the reduction of all therapeutic modalities, except for radiotherapy alone and associated with surgery+iodine therapy. However, it did not harm the number of new cases treated in a timely manner.

Indexed as

COVID-19NeoplasmsBrazilHumansPandemicsTime FactorsTime-to-Treatment

Identifiers

PMID40366936
PMCPMC12068809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.